GLP-2 TZ 30mg

GLP-2 TZ (Tirzepatide) is a synthetic dual receptor peptide supplied as a high-purity lyophilized powder for laboratory research applications. This research-grade GLP-2 TZ 30mg vial is manufactured under strict quality control standards and analytically verified to ensure purity, identity, and batch consistency. Tirzepatide is widely referenced in scientific literature examining dual incretin receptor interaction and peptide-mediated metabolic signaling pathways in controlled experimental environments.

Structurally classified as a dual GIP and GLP-1 receptor agonist, GLP-2 TZ (Tirzepatide) is studied in laboratory models for its receptor-binding profile and downstream signaling activity. In controlled research settings, Tirzepatide has been evaluated for its interaction with glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Researchers investigating peptide-receptor dynamics, incretin pathway signaling, and intracellular cascade modulation frequently reference GLP-2 TZ in experimental frameworks designed to analyze receptor activation kinetics and molecular response mechanisms.

The 30mg GLP-2 TZ (Tirzepatide) peptide is provided in lyophilized powder form to preserve structural integrity and support long-term molecular stability. Lyophilization removes moisture through a controlled freeze-drying process, helping maintain peptide conformation and minimize degradation during storage. This preservation method is widely utilized in peptide research due to its ability to enhance shelf stability and ensure reproducibility across laboratory applications. Each production batch undergoes analytical testing to confirm ≥99% purity, ensuring consistent material quality suitable for scientific investigation.

GLP-2 TZ (Tirzepatide) remains a compound of interest within metabolic and incretin receptor research due to its dual receptor-targeting design and modified peptide structure. Researchers studying peptide-mediated endocrine signaling, receptor engagement profiles, and synthetic dual-agonist compounds frequently include Tirzepatide in controlled experimental models examining pathway interaction and downstream signaling dynamics. Its structural stability and receptor specificity contribute to its continued evaluation in advanced laboratory research environments.

Each vial contains 30mg of GLP-2 TZ (Tirzepatide) as a white to off-white lyophilized powder. For optimal stability, store at -20°C under appropriate laboratory conditions and protect from excessive heat, light exposure, and repeated freeze-thaw cycles to preserve compound integrity.

This GLP-2 TZ (Tirzepatide) 30mg vial is supplied for laboratory research applications and intended for use by qualified professionals conducting controlled experimental studies involving dual incretin receptor agonist peptides.